News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
776,028 Results
Type
Article (66162)
Company Profile (187)
Press Release (709656)
Multimedia
Podcasts (190)
Webinars (30)
Section
Business (208935)
Career Advice (3136)
Deals (36362)
Drug Delivery (154)
Drug Development (83989)
Employer Resources (181)
FDA (17270)
Job Trends (15870)
News (356967)
Policy (34849)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (2949)
Academic (2)
Accelerated approval (46)
Adcomms (33)
Allergies (180)
Alliances (53140)
ALS (210)
Alzheimer's disease (1821)
Antibody-drug conjugate (ADC) (452)
Approvals (17594)
Artificial intelligence (721)
Autoimmune disease (268)
Automation (55)
Bankruptcy (337)
Best Places to Work (12145)
BIOSECURE Act (22)
Biosimilars (223)
Biotechnology (128)
Bladder cancer (189)
Brain cancer (75)
Breast cancer (736)
Cancer (5828)
Cardiovascular disease (481)
Career advice (2684)
Career pathing (47)
CAR-T (339)
CDC (66)
Celiac Disease (2)
Cell therapy (923)
Cervical cancer (47)
Clinical research (72233)
Collaboration (2136)
Company closure (7)
Compensation (1077)
Complete response letters (88)
COVID-19 (2918)
CRISPR (113)
C-suite (1135)
Cystic fibrosis (155)
Data (7640)
Decentralized trials (3)
Denatured (69)
Depression (165)
Dermatology (69)
Diabetes (581)
Diagnostics (7302)
Digital health (58)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (348)
Drug pricing (225)
Drug shortages (35)
Duchenne muscular dystrophy (275)
Earnings (85525)
Editorial (72)
Employer branding (21)
Employer resources (161)
Events (121664)
Executive appointments (1133)
FDA (20998)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (33)
Funding (1752)
Gene editing (246)
Generative AI (76)
Gene therapy (734)
GLP-1 (1105)
Government (5283)
Grass and pollen (8)
Guidances (405)
Healthcare (20259)
HIV (82)
Huntington's disease (50)
IgA nephropathy (95)
Immunology and inflammation (292)
Immuno-oncology (93)
Indications (170)
Infectious disease (3266)
Inflammatory bowel disease (220)
Inflation Reduction Act (16)
Influenza (143)
Intellectual property (285)
Interviews (594)
IPO (16642)
IRA (53)
Job creations (4077)
Job search strategy (2206)
JPM (71)
Kidney cancer (19)
Labor market (93)
Layoffs (634)
Leadership (46)
Legal (8388)
Liver cancer (103)
Longevity (30)
Lung cancer (772)
Lymphoma (424)
Machine learning (60)
Management (62)
Manufacturing (1032)
MASH (188)
Medical device (14823)
Medtech (14917)
Mergers & acquisitions (20989)
Metabolic disorders (1522)
mRNA (226)
Multiple sclerosis (183)
NASH (21)
Neurodegenerative disease (409)
Neuropsychiatric disorders (108)
Neuroscience (3320)
Neurotech (1)
NextGen: Class of 2026 (7170)
Non-profit (4982)
Now hiring (43)
Obesity (712)
Opinion (353)
Ovarian cancer (209)
Pain (255)
Pancreatic cancer (294)
Parkinson's disease (360)
Partnered (37)
Patents (595)
Patient recruitment (660)
Peanut (66)
People (64496)
Pharmaceutical (38)
Pharmacy benefit managers (32)
Phase 1 (22571)
Phase 2 (31654)
Phase 3 (23558)
Pipeline (7937)
Policy (352)
Postmarket research (2878)
Preclinical (9874)
Press Release (70)
Prostate cancer (298)
Psychedelics (56)
Radiopharmaceuticals (345)
Rare diseases (1077)
Real estate (6662)
Recruiting (76)
Regulatory (26621)
Reports (53)
Research institute (2689)
Resumes & cover letters (477)
Rett syndrome (37)
RNA editing (24)
RSV (89)
Schizophrenia (176)
Series A (298)
Series B (214)
Service/supplier (13)
Sickle cell disease (114)
Special edition (23)
Spinal muscular atrophy (175)
Sponsored (52)
Startups (3852)
State (2)
Stomach cancer (17)
Supply chain (127)
Tariffs (92)
The Weekly (118)
Vaccines (1181)
Venture capital (105)
Weight loss (474)
Women's health (121)
Worklife (24)
Date
Today (191)
Last 7 days (735)
Last 30 days (2870)
Last 365 days (31409)
2026 (10505)
2025 (31298)
2024 (35721)
2023 (40444)
2022 (51677)
2021 (56689)
2020 (55768)
2019 (49679)
2018 (37823)
2017 (34544)
2016 (34623)
2015 (40508)
2014 (34108)
2013 (30308)
2012 (31976)
2011 (31934)
2010 (30641)
Location
Africa (1053)
Alabama (97)
Alaska (7)
Arizona (332)
Arkansas (16)
Asia (45892)
Australia (8056)
California (12542)
Canada (3681)
China (1359)
Colorado (562)
Connecticut (572)
Delaware (398)
Europe (105044)
Florida (1906)
Georgia (426)
Hawaii (3)
Idaho (66)
Illinois (1076)
India (93)
Indiana (602)
Iowa (21)
Japan (528)
Kansas (135)
Kentucky (51)
Louisiana (42)
Maine (81)
Maryland (1544)
Massachusetts (9082)
Michigan (389)
Minnesota (725)
Mississippi (7)
Missouri (157)
Montana (37)
Nebraska (27)
Nevada (141)
New Hampshire (92)
New Jersey (3460)
New Mexico (32)
New York (3397)
North Carolina (1650)
North Dakota (9)
Northern California (6217)
Ohio (379)
Oklahoma (26)
Oregon (44)
Pennsylvania (2522)
Puerto Rico (28)
Rhode Island (46)
South America (1388)
South Carolina (87)
South Dakota (2)
Southern California (4957)
Tennessee (207)
Texas (2033)
United States (45353)
Utah (393)
Vermont (1)
Virginia (306)
Washington D.C. (80)
Washington State (1046)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
776,028 Results for "national institute of standards and technology nist".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
USP to Lead Development of Digital Quality Standards to Support Adoption and Regulatory Confidence
By expanding its digital offerings, USP will help quality specialists integrate quality standards into digital workflows with greater efficiency, consistency, and reduced risk
January 22, 2026
·
3 min read
Press Releases
Four Feinstein Institutes Scientists Honored as National Academy of Inventors Senior Members
March 1, 2026
·
4 min read
Press Releases
Leading Parkinson’s Organizations Urge Congress to Preserve Progress and Strengthen Parkinson’s Research Funding at the National Institutes of Health
April 5, 2026
·
4 min read
Press Releases
Boston Cell Standards Enters Final Phase of FDA MDDT Program to Qualify First-in-Industry Platform to Standardize Cancer Diagnostic Assays
April 27, 2026
·
4 min read
Press Releases
Phoenix Children’s Research Institute Secures Three Prestigious National Institutes of Health (NIH) Grants
December 19, 2025
·
5 min read
Biotech Bay
Mission Bio Announces High Precision Detection of Variants For Tapestri® Platform in NIST Genome Editing Consortium Initial Study
Mission Bio announced today initial results from the National Institute of Standards and Technology (NIST) Genome Editing Consortium’s inaugural Interlab Study.
October 23, 2023
·
4 min read
The US National Institute of Standards and Technology (NIST) has evaluated the use of Genomic Vision applications for genetic variant characterization
Bagneux – Genomic Vision, a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, is pleased to announce the successful evaluation of its DNA combing technology by the US National Institute of Standards and Technology.
February 21, 2023
·
5 min read
Press Releases
National Cancer Institute Awards Rosalind Franklin University Researcher Grant to Crack the Epigenetic Code of Pancreatic Cancer Muscle Wasting
March 26, 2026
·
1 min read
Press Releases
Made Scientific and New Jersey Institute of Technology Announce Partnership to Enhance Graduate-Level Cell and Gene Therapy Bioprocessing Curriculum
March 27, 2026
·
3 min read
Bio NC
BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization
BioSkryb Genomics today announced it has joined the NIST Genome Editing Consortium to help address the measurements and standards needed to increase confidence of utilizing genome editing technologies in research and commercial products.
September 13, 2023
·
3 min read
1 of 77,603
Next
